STAAR Surgical Future Growth
Future criteria checks 4/6
STAAR Surgical is forecast to grow earnings and revenue by 33.7% and 13.5% per annum respectively. EPS is expected to grow by 31% per annum. Return on equity is forecast to be 7.7% in 3 years.
Key information
33.7%
Earnings growth rate
31.0%
EPS growth rate
Medical Equipment earnings growth | 17.0% |
Revenue growth rate | 13.5% |
Future return on equity | 7.7% |
Analyst coverage | Good |
Last updated | 17 Dec 2024 |
Recent future growth updates
Recent updates
STAAR Surgical Company's (NASDAQ:STAA) Earnings Haven't Escaped The Attention Of Investors
Nov 29Return Trends At STAAR Surgical (NASDAQ:STAA) Aren't Appealing
Oct 24STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize
Sep 05Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher
Apr 26STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
Apr 05STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue
Mar 25STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade
Mar 13STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump
Mar 07Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
Jan 31With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For
Jan 05Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
Nov 30Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?
Nov 12Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Oct 25Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes
Aug 24Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?
Jul 02Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?
Jun 17Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
May 13A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Mar 26STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital
Mar 12Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?
Feb 13Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
Jan 28Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Dec 15The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising
Dec 01What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?
Oct 26Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
Sep 20Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
Sep 05STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 21Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 445 | 38 | 31 | 55 | 12 |
12/31/2025 | 386 | 18 | 19 | 39 | 14 |
12/31/2024 | 343 | 6 | 7 | 31 | 14 |
9/27/2024 | 341 | 22 | 26 | 47 | N/A |
6/28/2024 | 333 | 17 | 14 | 37 | N/A |
3/29/2024 | 326 | 15 | 21 | 41 | N/A |
12/29/2023 | 322 | 21 | -4 | 15 | N/A |
9/29/2023 | 310 | 20 | -34 | -14 | N/A |
6/30/2023 | 306 | 26 | -1 | 16 | N/A |
3/31/2023 | 295 | 33 | 17 | 35 | N/A |
12/30/2022 | 284 | 40 | 18 | 36 | N/A |
9/30/2022 | 279 | 38 | 22 | 41 | N/A |
7/1/2022 | 262 | 34 | 24 | 39 | N/A |
4/1/2022 | 243 | 29 | 19 | 33 | N/A |
12/31/2021 | 230 | 28 | 30 | 44 | N/A |
10/1/2021 | 217 | 23 | 44 | 55 | N/A |
7/2/2021 | 206 | 21 | 32 | 42 | N/A |
4/2/2021 | 179 | 11 | 28 | 36 | N/A |
1/1/2021 | 163 | 6 | 13 | 21 | N/A |
10/2/2020 | 156 | 9 | 2 | 11 | N/A |
7/3/2020 | 148 | 7 | 4 | 13 | N/A |
4/3/2020 | 153 | 13 | 7 | 17 | N/A |
1/3/2020 | 150 | 14 | 16 | 26 | N/A |
9/27/2019 | 142 | 9 | 11 | 18 | N/A |
6/28/2019 | 135 | 8 | 9 | 15 | N/A |
3/29/2019 | 129 | 6 | 7 | 11 | N/A |
12/28/2018 | 124 | 5 | 11 | 13 | N/A |
9/28/2018 | 118 | 4 | 10 | 12 | N/A |
6/29/2018 | 109 | 3 | N/A | 7 | N/A |
3/30/2018 | 97 | 1 | N/A | 6 | N/A |
12/29/2017 | 91 | -2 | N/A | 3 | N/A |
9/29/2017 | 88 | -2 | N/A | 2 | N/A |
6/30/2017 | 84 | -5 | N/A | 0 | N/A |
3/31/2017 | 84 | -6 | N/A | 3 | N/A |
12/30/2016 | 82 | -12 | N/A | 1 | N/A |
9/30/2016 | 81 | -13 | N/A | -1 | N/A |
7/1/2016 | 80 | -13 | N/A | -1 | N/A |
4/1/2016 | 78 | -12 | N/A | -3 | N/A |
1/1/2016 | 77 | -7 | N/A | -2 | N/A |
10/2/2015 | 73 | -8 | N/A | -4 | N/A |
7/3/2015 | 72 | -9 | N/A | -5 | N/A |
4/3/2015 | 74 | -9 | N/A | -8 | N/A |
1/2/2015 | 75 | -8 | N/A | -8 | N/A |
10/3/2014 | 77 | -7 | N/A | -5 | N/A |
7/4/2014 | 76 | -3 | N/A | -1 | N/A |
4/4/2014 | 74 | -1 | N/A | 1 | N/A |
1/3/2014 | 72 | 0 | N/A | 3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: STAA's forecast earnings growth (33.7% per year) is above the savings rate (2.6%).
Earnings vs Market: STAA's earnings (33.7% per year) are forecast to grow faster than the US market (15.2% per year).
High Growth Earnings: STAA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: STAA's revenue (13.5% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: STAA's revenue (13.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: STAA's Return on Equity is forecast to be low in 3 years time (7.7%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 03:35 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/27 |
Annual Earnings | 2023/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
STAAR Surgical Company is covered by 24 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Joanne Wuensch | BMO Capital Markets U.S. (Historical) |
Michael Gorman | BTIG |
John Young | Canaccord Genuity |